01972nam a22002297a 4500 D0001C000163 DOH 20210326111328.0 210326b ||||| |||| 00| 0 eng d rda COVID-19 rapid guideline : managing the long-term effects of COVID-19 managing the long-term effects of COVID-19 London : National Institute for Health and Care Excellence, 2020. rdacontent text rdamedia unmediated rdacarier volume This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It also includes advice on organising services for long COVID. This guideline has been developed jointly by NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP). To develop the recommendations, we have used the following clinical definitions for the initial illness and long COVID at different times: Acute COVID-19: signs and symptoms of COVID-19 for up to 4 weeks. Ongoing symptomatic COVID-19: signs and symptoms of COVID-19 from 4 to 12 weeks. Post-COVID-19 syndrome: signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis. When using this guideline, follow the usual professional guidelines, standards and laws (including those on equalities, safeguarding, communication and mental capacity), as described in making decisions using NICE guidelines. COVID-19 Long Term Adverse Effects Guideline https://www.ncbi.nlm.nih.gov/books/NBK567261/ nlm CV 3788 3788 0 0 nlm 0 0 DOHCL DOHCL ElectronicRes 2021-03-26 0 COVID-19-000163 D0001C000163 2021-03-26 00:00:00 2021-03-26 CV